What are Antibody Drug Conjugates, and do they have a promising future in lung cancer treatment? To discuss this topic, Lung Cancer Considered host Dr. Stephen Liu is joined by Dr. Rebecca Heist, associate director of clinical research at Massachusetts General Hospital Cancer Center in Boston, and Dr. Ben Levy, clinical director of medical oncology at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center in Baltimore.
Jun 07, 2022•39 min
India is an extremely diverse and populous country with just under 1.5 billion people. And as with every country in the world, lung cancer represents a major threat to public health. In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks about the state of lung cancer in India with Dr. Navneet Singh, Professor in the Department of Pulmonary Medicine at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh, India.
May 31, 2022•32 min
Providing smoking cessation without contributing to the stigma faced by those who smoke is a worthwhile goal. To discuss this in greater detail, Lung Cancer Considered host Dr. Narjust Duma welcomes Dr. Jamie Ostroff, Dr. Matthew Steliga, and Jim Pantelas. Dr. Ostroff is the Joseph Gaumont Chair of Cancer Prevention and the Director of the Memorial Sloan Kettering Tobacco Treatment Program and Dr. Steliga is an Associate Professor in Surgery at the University of Arkansas Medical Center and a mem...
May 17, 2022•44 min
Dr. Hilary Robbins, an epidemiologist with the International Agency for Research on Cancer, and Dr. Brendon Stiles, chief of Thoracic Surgery and Surgical Oncology at Montefiore-Einstein Cancer Center in New York, join Lung Cancer Considered host Dr. Stephen Liu to discuss the current status of lung cancer screening research and challenges to implementing it on a national and international scale.
May 03, 2022•39 min
On a special Earth Day episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by two vocal IASLC members who have taken a passionate interest in understanding more about the climate crisis and how it impacts our patients with lung cancer.
Apr 22, 2022•48 min
In the 100th episode of IASLC's Lung Cancer Considered, host Dr. Narjust Duma interviews new IASLC CEO, Dr. Karen Kelly. Dr. Kelly is recognized internationally for her expertise in lung cancer research and her career has been dedicated to providing enhanced cancer care through innovative and groundbreaking clinical trials. Dr. Kelly’s lung cancer research has involved all aspects of the disease from risk reduction to screening to treatment. She has been at the forefront of drug development to t...
Apr 19, 2022•38 min
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently completed European Lung Cancer Congress. His guests include Dr. Lizza Hendriks, assistant professor at Maastricht University in the Netherlands. Dr. Hendriks is also a pulmonologist specializing in thoracic oncology and the program leader of the Innovative Cancer Diagnostics Therapy group at GROW School of Oncology. Joining Dr. Hendriks is Dr. Nicolas Girarda, professor of Respiratory Medicine at the Versaille...
Apr 05, 2022•27 min
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.
Mar 15, 2022•33 min
The IASLC Targeted Therapies Meeting has historically been a very interactive, fast-paced meeting that highlights the latest and most innovative anticancer drugs, initially focused on targeted agents but in recent years, extending to immunotherapy. In this Lung Cancer Considered podcast hosts Dr. Narjust Duma and Dr. Stephen Liu lead a wide-ranging discussion of the meeting with three lung cancer experts who attended the meeting: Dr. Lecia Sequist is a thoracic medical oncologist at Massachusett...
Mar 01, 2022•49 min
Neurotrophic tyrosine receptor kinase fusion, or NTRK, has emerged in the last six years as a rare, but targetable alteration in several cancers. Dr. Herbert Loong, clinical assistant professor in the department of clinical oncology and deputy medical director of the Phase 1 Clinical Trials Center of The Chinese University of Hong Kong, joins Lung Cancer Considered host Dr. Stephen Liu to discuss NTRK and what impact it may have on lung cancer research and treatment.
Feb 22, 2022•27 min
Lung Cancer Considered hosts Dr. Narjust Duma and Dr. Stephen Liu discuss ALK-fusion positive NSCLC with Dr. Jessica Lin, a physician at the Massachusetts General Hospital Cancer Center and an Assistant Professor of Medicine at Harvard Medical School, and Dr. Ben Solomon, a professor and consultant medical oncologist at Peter MacCallum Cancer Center in Melbourne, Australia.
Feb 15, 2022•46 min
In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks with Dr. Zosia Piotrowska, Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital in Boston, Mass., about the current and future state of therapies for patients with EGFR mutant lung cancer.
Feb 01, 2022•31 min
Cell therapy has made strides in hematology and oncology and has recently shown promise in thoracic oncology. In this episode of Lung Cancer Considered host, Dr. Narjust Duma delves into this emerging therapy with guests Dr. Ben Creelan, associate professor of medicine at the University of South Florida, thoracic oncologist at Moffitt Cancer Center and Dr. Prasad Adusumilli, deputy chief and attending of the thoracic service, vice chair for translational research in the department of surgery at ...
Jan 18, 2022•37 min
This episode of Lung Cancer Considered focuses on an EGFR mutant non-small cell lung cancer virtual tumor board case that involves a 41-year-old woman who is a never smoker and presents with a dry cough, chest pain, and weight loss. Discussing treatment options on this podcast with host Dr. Narjust Duma are Dr. Alfredo Addeo, senior oncologist at Geneva Hospital in Geneva, Switzerland, and Dr. Helena Yu, medical oncologist at Memorial Sloan Kettering Cancer Center in New York City.
Jan 04, 2022•44 min
Dr. Jacques Cadranel, Head of Department Pulmonology and Thoracic Oncology, Assistance Publique Hôpitaux de Paris and Sorbonne University and Dr Janessa Laskin, Medical Oncologist at the Vancouver Cancer Centre in British Columbia, Canada join Lung Cancer Considered Host Dr. Narjust Duma to discuss current and promising breakthrough therapies in lung cancer.
Dec 28, 2021•42 min
Dr. Narjust Duma hosts a spirited Spanish-language edition of Lung Cancer Considered on the recently completed 2021 LALCA Schools of Thoracic Oncology meeting with Luis E. Raez, MD, Chief Scientific Officer & Medical Director Memorial Cancer Institute/Memorial Health Care System; Lucia Viola, MD, Interventional Pulmonologist, Head of Thoracic Oncology Service, Fundación Neumológica Colombiana and Christian Rolfo, MD, PhD, Professor and Assoc. Director for Clinical Research, Center for Thorac...
Dec 21, 2021•37 min
Lung Cancer Considered host Dr. Stephen Liu discusses a virtual tumor board with guests Dr. Anthony Kim, professor of clinical surgery and chief of thoracic surgery at The Keck School of Medicine at the University of Southern California and Dr. Patricia Rivera, professor of medicine at University of North Carolina and director of the UNC Lung Cancer Screening Initiative. The case involves a 45-year-old woman with stage III non-small cell lung cancer.
Dec 07, 2021•41 min
In this new episode of Lung Cancer Considered, podcast host Dr. Narjust Duma interviews three IASLC Patient Research Advocates who are part of the IASLC Supportive Training for Advocates on Research & Science (STARS) program: Caleb Egwuenu comes from Nigeria and participated in STARS for two years as a Patient Research Advocate: Erika Hlavacek, a Patient Research Advocate and founder of nonprofit yEAHbestlife from Illinois; and Lillian Leigh, STARS mentor from Australia.
Dec 01, 2021•40 min
Globally, lung cancer is the single most lethal cancer, accounting for 1.8 million deaths last year, yet research funding devoted to lung cancer pales in comparison to other cancer types. In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses how global advocacy might play a role in addressing this gap. His guest is Dr. Anne-Marie Baird, a cancer researcher at Trinity College in Dublin, Ireland. Dr. Baird is the former Chair of the IASLC Communications Committee, and the newly...
Nov 30, 2021•29 min
In a special Korean-language Lung Cancer Considered episode, leading lung cancer specialists discuss the state of the disease in South Korea. Host Dr. Chul Kim, assistant professor of Medicine and Thoracic Medical Oncologist at Georgetown University, interviews Dr. Young Tae Kim, professor of the Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine and Dr. Sun Min Lim, assistant professor of the Department of Internal Medicine, Yonsei University Colleg...
Nov 22, 2021•50 min
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on a virtual tumor board case focusing on a patient with stage III NSCLC. Guests are Dr. Erin Gillaspie, assistant professor of Thoracic Surgery at Vanderbilt University in Nashville, Tenn., and Dr. Shankar Siva, associate professor at the University of Melbourne, in Victoria, Australia.
Nov 22, 2021•41 min
Professional Golfer Jason Day has known success in his career--he has been the top ranked PGA player and won the PGA Championship in 2015. Unfortunately, that year Jason’s mother Denning was diagnosed with state IV non-small-cell lung cancer, spurring Jason to become a passionate advocate for lung cancer research and treatment. Tune into this episode of Lung Cancer Considered to hear about how he became a lung cancer advocate and how his mother’s health drove him to become an advocate for biomar...
Nov 09, 2021•28 min
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Heidi Nafman-Onda and her husband Dr. Pierre Onda, the founders of The White Ribbon project, and patient advocate/activist Chris Draft from the Chris Draft Family Foundation.
Oct 30, 2021•54 min
This episode of Lung Cancer Considered looks ahead to the IASLC 2021 Hot Topic Meeting on Small Cell Lung Cancer, scheduled for Oct 29th and 30th 2021. Host Dr. Stephen Liu discusses the state of the SCLC research with Dr. Tripnara Sen, an Assistant Attending Biologist in the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center and Dr. Charles Rudin, the co-director of the Druckenmiller Center for Lung Cancer Research and the Sylvia Hassenfeld Chair in Lung Cancer Research, also f...
Oct 26, 2021•26 min
Tune in to Lung Cancer Considered as host Dr. Stephen Liu discusses a virtual tumor board case involving a patient with small cell lung cancer. Guests include Dr. Lauren Byers, associate professor of Medicine at The University of Texas MD Anderson Cancer Center, and Dr. Ponce Aix, from the Gustave Roussy in Paris, France.
Oct 19, 2021•32 min
In this episode of Lung Cancer Considered, podcast guests Dr. Solange Peters, current ESMO president, and Dr. Pasi Janne, co-chair of ESMO 2021, discuss the recently concluded ESMO meeting and share the meeting’s most significant lung cancer research findings with podcast host Dr. Narjust Duma.
Oct 14, 2021•32 min
The intersection of medicine and politics is fascinating and often controversial and contentious. In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks to two physicians who have entered the political arena—Dr. Nasser Hanna, who ran in Indiana’s 5th Congressional District and Dr. Raja Flores, who is running for Mayor of New York City.
Oct 06, 2021•49 min
In this episode of Lung Cancer Considered, Dr. Nathan Pennell, from the Cleveland Clinic, and Podcast host Dr. Narjust Duma, from Dana Farber Cancer Institute, share information about how lung cancer care has changed in the 14 years Dr. Pennell has been in practice.
Sep 18, 2021•42 min
The IASLC 2021 World Conference on Lung Cancer co-chairs Dr. David Harpole, Dr. Kristin Higgins, Dr. Thomas Stinchcombe join Lung Cancer Considered Hosts Dr. Narjust Duma and Dr. Stephen Liu to cover highlights of the recently concluded virtual meeting. Tune in to hear these IASLC members discuss the most significant research developments from the conference.
Sep 15, 2021•45 min
In this episode of Lung Cancer Considered , Dr. Heather Wakelee and Dr. Paul Van Schil join hosts Dr. Narjust Duma and Dr. Stephen Liu to discuss priorities and initiatives for IASLC in the 2021-22 year. Dr. Wakelee takes the reins as President of the IASLC this month during WCLC, the second woman to achieve this honor. Dr. Van Schil begins his term as President-Elect of the IASLC during WCLC, too.
Sep 07, 2021•42 min
